Hemerion
Lille, FR · 2 known investors
Find your way into Hemerion
Sign up to see every warm intro you have to Hemerion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hemerion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hemerion develops photonic drug-device combination therapies for treating glioblastomas and other brain tumors in clinical settings. The company combines photosensitizing drugs with innovative photonic systems designed to integrate into surgical workflows and selectively destroy tumor cells.
Founders & leadership
MV

Maximilien VermandelMaximilien Vermandel holds a Master's degree in Automatic and Signal Processing from the University of Lille and a Master's degree in Medical Physics from the University Paul Sabatier, with nearly two decades of academic and research experience in brain tumor treatment. He was an associate professor at the University Hospital of Lille, where he led a research group focused on photodynamic therapy in neurosurgery, and is now founding Hemerion to develop photonic drug-device therapies for glioblastoma.
Investors · 2
Capital Celllisted by Capital CellBarcelona
How we know: Capital Cell's portfolio page · Not right? Tell us
BpifrancereportedParis, Ile-De-France · $270K
How we know: funding news · hemerion.com · Not right? Tell us
In the news
Frequently asked questions
- What does Hemerion do?
- Hemerion develops photonic drug-device combination therapies for treating glioblastomas and other brain tumors in clinical settings. The company combines photosensitizing drugs with innovative photonic systems designed to integrate into surgical workflows and selectively destroy tumor cells.
- Who founded Hemerion?
- Hemerion was founded by Maximilien Vermandel.
- Who are Hemerion's investors?
- Hemerion's investors include Capital Cell, Bpifrance.
- Where is Hemerion headquartered?
- Hemerion is headquartered in Lille, FR.

